Aura Biosciences, Inc. Earnings Per Share, Basic and Diluted
Aura Biosciences, Inc. (AURA) reported Earnings Per Share, Basic and Diluted of -$0.44 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-12.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-05-12
- Aura Biosciences, Inc. earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$0.44.
- Aura Biosciences, Inc. earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$0.60.
- Aura Biosciences, Inc. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$28.33.
- Aura Biosciences, Inc. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$20.62.
- Aura Biosciences, Inc. earnings per share, basic and diluted for fiscal 2021 was -$8.95.
- Aura Biosciences, Inc. earnings per share, basic and diluted for fiscal 2020 was -$82.06.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-03-31 | -$0.44 10-Q · filed 2022-05-12 | -$1.01 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$2.04 derived: net income ÷ weighted average shares · filed 2023-11-09 | |
| 2021-12-31 | -$0.60 derived: net income ÷ weighted average shares · filed 2023-03-15 | -$2.07 derived: net income ÷ weighted average shares · filed 2023-03-15 | -$8.95 10-K · filed 2022-03-23 | |
| 2021-09-30 | -$28.33 10-Q · filed 2021-11-24 | -$77.93 10-Q · filed 2021-11-24 | ||
| 2021-03-31 | -$20.62 10-Q · filed 2022-05-12 | -$27.74 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$37.48 derived: net income ÷ weighted average shares · filed 2022-11-10 | |
| 2020-12-31 | -$12.89 derived: net income ÷ weighted average shares · filed 2022-03-23 | -$22.55 derived: net income ÷ weighted average shares · filed 2022-03-23 | -$82.06 10-K · filed 2022-03-23 | |
| 2020-09-30 | -$14.81 10-Q · filed 2021-11-24 | -$63.69 10-Q · filed 2021-11-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B |